Windtree Therapeutics, Inc. (WINT)

Windtree Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	4.47	6.33	22.5	17.08	22.73
Cash & Cash Equivalents	4.47	6.33	22.5	17.08	22.73
Cash Growth	-29.36%	-71.89%	31.71%	-24.85%	-10.21%
Other Current Assets	0.91	1.05	0.99	1.03	1.13
Total Current Assets	5.38	7.38	23.49	18.12	23.86
Property, Plant & Equipment	1.63	2.12	3.39	1.84	2.19
Goodwill and Intangibles	25.25	28.31	47.75	92.77	92.77
Other Long-Term Assets	0.15	0.15	0.15	0.15	0.15
Total Long-Term Assets	27.03	30.58	51.3	94.77	95.11
Total Assets	32.41	37.95	74.79	112.89	118.98
Accounts Payable	0.81	0.25	0.69	1.16	3.68
Current Debt	0.67	0.66	0.82	1.16	0.91
Other Current Liabilities	2.52	1.55	3.41	3.81	3.23
Total Current Liabilities	4	2.46	4.92	6.13	7.82
Long-Term Debt	1.16	1.62	2.07	2.62	5.4
Other Long-Term Liabilities	23.86	23.86	25.91	34.58	30.82
Total Long-Term Liabilities	25.02	25.49	27.99	37.2	36.22
Total Liabilities	29.02	27.94	32.91	43.33	44.04
Total Debt	1.83	2.28	2.89	3.78	6.31
Debt Growth	-19.74%	-21.19%	-23.49%	-40.11%	-20.83%
Retained Earnings	-844.82	-824.53	-785.32	-717.69	-685.12
Shareholders' Equity	3.39	10.01	41.88	69.55	74.94
Net Cash / Debt	2.64	4.05	19.61	13.3	16.42
Net Cash / Debt Growth	-34.78%	-79.37%	47.40%	-18.98%	-5.33%
Net Cash Per Share	12.26	115.60	713.05	764.85	1352.25
Working Capital	1.38	4.92	18.57	11.99	16.04
Book Value Per Share	15.75	286.06	1522.94	3998.85	6171.55

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).